Our results indicated that CSTF2 could affect the IC50 value of multiple drugs, suggesting that CSTF2 may affect the therapeutic effect of multiple drugs on cancer patients, and thereby affect the prognosis of cancer patients. This evidence concerns the gene CSTF2 and cancer.